{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Mortierella polycephala", "VEGFR2 kinase inhibitors", "azaphilonoid pigments", "molecular docking"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34265877", "DateCompleted": {"Year": "2022", "Month": "01", "Day": "17"}, "DateRevised": {"Year": "2022", "Month": "01", "Day": "17"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "07", "Day": "16"}], "Language": ["eng"], "ELocationID": ["10.1515/znc-2021-0095"], "Journal": {"ISSN": "1865-7125", "JournalIssue": {"Volume": "77", "Issue": "1-2", "PubDate": {"Year": "2022", "Month": "Jan", "Day": "27"}}, "Title": "Zeitschrift fur Naturforschung. C, Journal of biosciences", "ISOAbbreviation": "Z Naturforsch C J Biosci"}, "ArticleTitle": "Monascin and monascinol, azaphilonoid pigments from <i>Mortierella polycephala</i> AM1: <i>in silico</i> and <i>in vitro</i> targeting of the angiogenic VEGFR2 kinase.", "Pagination": {"StartPage": "11", "EndPage": "19", "MedlinePgn": "11-19"}, "Abstract": {"AbstractText": ["The fungus, <i>Mortierella polycephala</i> is one of the most productive sources of anticancer bioactive compounds namely those of pigment nature. During our investigation of the produced bioactive metabolites by the terrestrial <i>M. polycephala</i> AM1 isolated from Egyptian poultry feather waste, two main azaphilonoid pigments, monascin (<b>1</b>) and monascinol (<b>2</b>) were obtained as major products; their structures were identified by 1D (<sup>1</sup>H&<sup>13</sup>C) and 2D (<sup>1</sup>H-<sup>1</sup>H COSY, HMBC) NMR and HRESI-MS spectroscopic data. Biologically, cytotoxic activities of these compounds were broadly studied compared with the fungal extract. To predict the biological target for the presumed antitumor activity, an <i>in silico</i> study was run toward three proteins, topoisomerase II<i>\u03b1</i>, topoisomerase II<i>\u03b2</i>, and VEGFR2 kinase. Monascinol (<b>2</b>) was expected to be moderately active against VEGFR2 kinase without any anticipated inhibition toward topo II isoforms. The <i>in vitro</i> study confirmed the docked investigation consistently and introduced monascinol (<b>2</b>) rather than its counterpart (<b>1</b>) as a potent inhibitor to the tested VEGFR2 kinase. Taxonomically, the fungus was identified using morphological and genetic assessments."], "CopyrightInformation": "\u00a9 2021 Walter de Gruyter GmbH, Berlin/Boston."}, "AuthorList": [{"Identifier": ["0000-0001-9281-2505"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemistry of Natural Compounds Department, Division of Pharmaceutical Industries, National Research Centre, El-Behoos St. 33, Dokki, Cairo, 12622, Egypt."}, {"Identifier": [], "Affiliation": "Department of Biotechnology and Biomedicine, Technical University of Denmark, S\u00f8ltofts Plads, Building 221, 2800 Kgs, Lyngby, Denmark."}], "LastName": "Shaaban", "ForeName": "Mohamed", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Botany and Microbiology Department, Faculty of Science, Damanhour University, Damanhour, Egypt."}], "LastName": "Magdy El-Metwally", "ForeName": "Mohammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Fungal Identification Unit, The Regional Center of Mycology and Biotechnology, Al-Azhar University, Nasr City, Cairo, Egypt."}], "LastName": "Mekawey", "ForeName": "Amal A I", "Initials": "AAI"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Plant Advanced Technologies, 19 Avenue de la For\u00eat de Haye, 54500, Vandoeuvre-l\u00e8s-Nancy, France."}], "LastName": "Abdelwahab", "ForeName": "Ahmed B", "Initials": "AB"}, {"Identifier": ["0000-0002-7370-0142"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biology Unit, Central Laboratory for Pharmaceutical and Drug Industries Research Division, Chemistry of Medicinal Plants Department, National Research Centre, Dokki, Cairo, 12622, Egypt."}], "LastName": "Soltan", "ForeName": "Maha M", "Initials": "MM"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Z Naturforsch C J Biosci", "NlmUniqueID": "8912155", "ISSNLinking": "0341-0382"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Heterocyclic Compounds, 3-Ring"}, {"RegistryNumber": "W74D2M37FX", "NameOfSubstance": "monascin"}], "SupplMeshList": ["Mortierella polycephala"], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": [], "DescriptorName": "Heterocyclic Compounds, 3-Ring"}, {"QualifierName": [], "DescriptorName": "Mortierella"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Sawadogo, WR, Schumacher, M, Teiten, M-H, Cerella, C, Dicato, M, Diederich, M. A survey of marine natural compounds and their derivatives with anti-cancer activity reported in 2011. Molecules 2013;18:3641\u201373. https://doi.org/10.3390/molecules18043641."}, {"Citation": "WHO. Global status report on noncommunicable diseases 2010; WT 500. Geneva, Switzerland: WHO; 2011."}, {"Citation": "Mangal, M, Sagar, P, Singh, H, Raghava, GP, Agarwal, SM. NPACT: naturally occurring plant-based anti-cancer compound-activity target database. Nucleic Acids Res 2012;41:D1124\u20139. https://doi.org/10.1093/nar/gks1047."}, {"Citation": "Elrayess, RA, Gad El-Hak, HN. Anticancer natural products: a review. Cancer Stud Mol Med Open J 2019;5:14\u201325. https://doi.org/10.17140/csmmoj-5-127."}, {"Citation": "Strobel, G, Daisy, B. Bioprospecting for microbial endophytes and their natural products. Microbiol Mol Biol Rev 2003;67:491\u2013502. https://doi.org/10.1128/mmbr.67.4.491-502.2003."}, {"Citation": "Xia, Y, Amna, A, Opiyo, SO. The culturable endophytic fungal communities of switchgrass grown on a coalmining site and their effects on plant growth. PloS One 2018;13:1\u201316. https://doi.org/10.1371/journal.pone.0198994."}, {"Citation": "Hardoim, PR, van Overbeek, LS, Berg, G, Pirttil\u00e4, AM, Compant, S, Campisano, A, et al.. The hidden world within plants: ecological and evolutionary considerations for defining functioning of microbial endophytes. Microbiol Mol Biol Rev 2015;79:293\u2013320. https://doi.org/10.1128/mmbr.00050-14."}, {"Citation": "Kaul, S, Gupta, S, Ahmed, M, Dhar, MK. Endophytic fungi from medicinal plants: a treasure hunt for bioactive metabolites. Phytochemistry Rev 2012;11:487\u2013505. https://doi.org/10.1007/s11101-012-9260-6."}, {"Citation": "Pimentel, MR, Molina, G, Dionisio, AP, Mar\u00f3stica, MR, Pastore, GM. Use of endophytes to obtain bioactive compounds and their application in biotransformation process. Biotechnol Res Int 2011;2011:576286. https://doi.org/10.4061/2011/576286."}, {"Citation": "Sarasan, M, Puthumana, J, Job, N, Han, J, Lee, J-S, Philip, R. Marine algicolous endophytic fungi-a promising drug resource of the era. J Microbiol Biotechnol 2017;27:1039\u201352. https://doi.org/10.4014/jmb.1701.01036."}, {"Citation": "Akihisa, T, Tokuda, H, Ukiya, M, Kiyota, A, Yasukawa, K, Sakamoto, N, et al.. Antitumor-initiating effects of monascin, an azaphilonoid pigment from the extract of Monascus pilosus fermented rice (red-mold rice). Chem Biodivers 2005;2:1305\u20139. https://doi.org/10.1002/cbdv.200590101."}, {"Citation": "Chen, RJ, Hung, CM, Chen, YL, Wu, MD, Yuan, GF, Wang, YJ. Monascuspiloin induces apoptosis and autophagic cell death in human prostate cancer cells via the Akt and AMPK signaling pathways. J Agric Food Chem 2012;60:7185\u201393. https://doi.org/10.1021/jf3016927."}, {"Citation": "Ho-Cheng, W, Hsun-Shuo, C, Ming-Jen, C, Ming-Der, W, Yen-Lin, C, Kai-Ping, C, et al.. Secondary metabolites from the fermented rice of the fungus Monascus purpureus and their bioactivities. Nat Prod Res 2019;33:3541\u201350."}, {"Citation": "Li, X, Liu, C, Duan, Z, Guo, S. HMG-CoA reductase inhibitors from monascus-fermented rice. J Chem 2013;2013:1\u20136. https://doi.org/10.1155/2013/872056."}, {"Citation": "Akihisa, T, Tadashi, Y, Takashi, S, Fukuoka, T. Monascinol and tumor promoter activity inhibitors and food containing it. Patent No. JP2008056618A; 2006."}, {"Citation": "Lin, C-H, Lina, T-H, Pan, T-M. Alleviation of metabolic syndrome by monascin and ankaflavin: the perspective of Monascus functional foods. Food Funct 2017;8:2102\u20139. https://doi.org/10.1039/c7fo00406k."}, {"Citation": "Lee, C-L, Wen, J-Y, Hsu, Y-W, Pan, T-M. Monascus-fermented yellow pigments monascin and ankaflavin showed antiobesity effect via the suppression of differentiation and lipogenesis in obese rats fed a high-fat diet. J Agric Food Chem 2013;61:1493\u2013500. https://doi.org/10.1021/jf304015z."}, {"Citation": "Lee, C-L, Wen, J-Y, Hsu, Y-W, Pan, T-M. Monascin and ankaflavin have more anti-atherosclerosis effect and less side effect involving increasing creatinine phosphokinase activity than monacolin K under the same dosages. J Agric Food Chem 2013;61:143\u201350. https://doi.org/10.1021/jf304346r."}, {"Citation": "Hsu, W-H, Chen, T-H, Lee, B-H, Hsu, Y-W, Pan, T-M. Monascin and ankaflavin act as natural AMPK activators with PPAR\u03b1 agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice. Food Chem Toxicol 2014;64:94\u2013103. https://doi.org/10.1016/j.fct.2013.11.015."}, {"Citation": "Nitiss, JL. Targeting DNA topoisomerase II in cancer chemotherapy. Nat Rev Canc 2009;9:338\u201350. https://doi.org/10.1038/nrc2607."}, {"Citation": "Lian, L, Li, X-L, Xu, M-D, Li, X-M, Wu, M-Y, Zhang, Y, et al.. VEGFR2 promotes tumorigenesis and metastasis in a pro-angiogenic-independent way in gastric cancer. BMC Canc 2019;19:183. https://doi.org/10.1186/s12885-019-5322-0."}, {"Citation": "RCSB protein data bank-RCSB PDB. Available from: http://www.rcsb.org/pdb/home/home.do."}, {"Citation": "Trott, O, Olson, AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010;31:455\u201361. https://doi.org/10.1002/jcc.21334."}, {"Citation": "Classen, S, Olland, S, Berger, JM. Structure of the topoisomerase II ATPase region and its mechanism of inhibition by the chemotherapeutic agent ICRF-187. Proc Natl Acad Sci U S A 2003;100:10629\u201334. https://doi.org/10.1073/pnas.1832879100."}, {"Citation": "Pastor, N, Dom\u00ednguez, I, Orta, ML, Campanella, C, Mateos, S, Cort\u00e9s, F. The DNA topoisomerase II catalytic inhibitor merbarone is genotoxic and induces endoreduplication. Mutat Res Fund Mol Mech Mutagen 2012;738\u2013739:45\u201351. https://doi.org/10.1016/j.mrfmmm.2012.07.005."}, {"Citation": "Skok, \u017d, Zidar, N, Kikelj, D, Ila\u0161, J. Dual inhibitors of human DNA topoisomerase II and other cancer-related targets. J Med Chem 2020;63:884\u2013904. https://doi.org/10.1021/acs.jmedchem.9b00726."}, {"Citation": "Fisher, FW, Cook, NB. Fundamentals of diagnostic mycology. Philadelphia, PA: Saunders; 1998."}, {"Citation": "Martin, BE, Pamela, JE. Microfungi on land plants, an identification handbook. New England: Richmond Publishing; 1985."}, {"Citation": "Orgensen, JH, Turnidge, JD. Susceptibility test methods: dilution and disk diffusion methods. In: Murray, PR, Baron, EJ, Jorgensen, JH, Landry, ML, Pfaller, MA, editors. Manual of clinical microbiology, 9th ed. Washington, D.C: ASM Press; 2007:1152\u201372 pp."}, {"Citation": "Sajid, I, Fondja, YCB, Shaaban, KA, Hasnain, S, Laatsch, H. Antifungal and antibacterial activities of indigenous Streptomyces isolates from saline farmlands: prescreening, ribotyping and metabolic diversity. World J Microbiol Biotechnol 2009;25:601\u201310. https://doi.org/10.1007/s11274-008-9928-7."}, {"Citation": "Pedretti, A, Villa, L, Vistoli, G. Atom-type description language: a universal language to recognize atom types implemented in the VEGA program. Theor Chem Acc 2003;109:229\u201332. https://doi.org/10.1007/s00214-002-0402-6."}, {"Citation": "Morris, GM, Huey, R, Lindstrom, W, Sanner, MF, Belew, RK, Goodsell, DS, et al.. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 2009;30:2785\u201391. https://doi.org/10.1002/jcc.21256."}, {"Citation": "Schrodinger. The PyMOL molecular graphics system. Version 1.8 Schr\u00f6dinger, LLC; 2015."}, {"Citation": "Wei, H, Ruthenburg, AJ, Bechis, SK, Verdine, GL. Nucleotide-dependent domain movement in the ATPase domain of a human type IIA DNA topoisomerase. J Biol Chem 2005;280:37041\u20137. https://doi.org/10.1074/jbc.m506520200."}, {"Citation": "Wu, C-C, Li, T-K, Farh, L, Lin, L-Y, Lin, T-S, Yu, Y-J, et al.. Structural basis of type II topoisomerase inhibition by the anticancer drug etoposide. Science 2011;333:459\u201362. https://doi.org/10.1126/science.1204117."}, {"Citation": "Oguro, Y, Miyamoto, N, Okada, K, Takagi, T, Iwata, H, Awazu, Y, et al.. Design, synthesis, and evaluation of 5-methyl-4-phenoxy-5H-Pyrrolo[3,2-d]Pyrimidine derivatives: novel VEGFR2 kinase inhibitors binding to inactive kinase conformation. Bioorg Med Chem 2010;18:7260\u201373. https://doi.org/10.1016/j.bmc.2010.08.017."}], "ReferenceList": [], "Title": "References"}], "History": [{"Year": "2021", "Month": "4", "Day": "2"}, {"Year": "2021", "Month": "6", "Day": "15"}, {"Year": "2021", "Month": "7", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "7", "Day": "15", "Hour": "20", "Minute": "37"}], "PublicationStatus": "epublish", "ArticleIdList": ["34265877", "10.1515/znc-2021-0095", "znc-2021-0095"]}}], "PubmedBookArticle": []}